Quest PharmaTech (TSXV:QPT) Net Change in Cash : C$-0.39 Mil (TTM As of Oct. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Quest PharmaTech's Net Change in Cash for the three months ended in Oct. 2023 was C$-0.01 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Oct. 2023 was C$-0.39 Mil.

Quest PharmaTech Net Change in Cash Historical Data

The historical data trend for Quest PharmaTech's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Net Change in Cash Chart

Quest PharmaTech Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Net Change in Cash

Get a 7-Day Free Trial

-0.07

1.81

-1.95

0.07

0.11

Quest PharmaTech Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Net Change in Cash	Get a 7-Day Free Trial															-0.04	-0.11	-0.28	0.01	-0.01

Quest PharmaTech Net Change in Cash Calculation

Quest PharmaTech's Net Change in Cash for the fiscal year that ended in Jan. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-0.555	+	-0.014	+	0.679	+	0
	=	0.11

Quest PharmaTech's Net Change in Cash for the quarter that ended in Oct. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.007 + 0 + 0 + 0

= -0.01

Net Change in Cash for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest PharmaTech Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Quest PharmaTech's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest PharmaTech (TSXV:QPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Net Change in Cash

Comparable Companies

TSXV:IOT TSXV:RKV TSXV:IBO XCNQ:MESC TSXV:MRVL TSX:APLI XCNQ:AGN XCNQ:MBIO TSXV:HEM XCNQ:DRUG OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX

Traded in Other Exchanges

N/A

Address

8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4

Website

http://www.questpharmatech.com

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Executives

Ragupathy Madiyalakan Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines